111 related articles for article (PubMed ID: 955351)
21. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
[TBL] [Abstract][Full Text] [Related]
22. The significance of HB antigenemy in apparently healthy persons in the clinic for liver diseases.
Lesnicar J; Zaversnik H; Ferluga D; Krk C
Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):297-304. PubMed ID: 1199669
[TBL] [Abstract][Full Text] [Related]
23. Clinical and epidemiological significance of the HBSAg (Australia antigen): carrier state.
Feinman SV; Cooter N; Sinclair JC; Wobel DM; Berris B
Gastroenterology; 1975 Jan; 68(1):113-20. PubMed ID: 1116653
[TBL] [Abstract][Full Text] [Related]
24. [A comparative analysis of blood donors with antibodies to the hepatitis C virus, positivity for the hepatitis B surface antigen and hypertransaminasemia in Asturias].
Suárez A; Riestra S; Rodríguez M; Linares A; Otero L; Rodrigo L
Med Clin (Barc); 1994 Jul; 103(6):209-13. PubMed ID: 7967864
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B surface antigen and immunoglobulin M complexes in chronic carriers and patients with acute and chronic liver diseases.
Ayoola EA; Olubuyide I
Afr J Med Med Sci; 1989 Mar; 18(1):21-4. PubMed ID: 2545079
[TBL] [Abstract][Full Text] [Related]
26. [Behavior of specific antibodies against hepatitis B surface antigen in children with acute and chronic hepatitides in healthy carriers and in various co-habitants of chronic hepatitis patients].
Jannuzzi C; Campelli A; Marazzi MG; Fabbri A
Boll Ist Sieroter Milan; 1976; 55(6):524-9. PubMed ID: 1023891
[TBL] [Abstract][Full Text] [Related]
27. Chronic asymptomatic HBSAg carriers: histologic abnormalities and diagnostic and prognostic value of serologic markers of the HBV.
De Franchis R; D'Arminio A; Vecchi M; Ronchi G; Del Ninno E; Parravicini A; Ferroni P; Zanetti AR
Gastroenterology; 1980 Sep; 79(3):521-7. PubMed ID: 7429112
[TBL] [Abstract][Full Text] [Related]
28. Study on hepatitis B antigen subtypes in donors with antigenaemia and viral hepatitis patients in several towns of the Soviet Union.
Barinsky IF; Kantorovich RA; Chimbru VI; Reizis AR; Semendyaeva ME; Tsibulyak SN; Rudenskaya IN; Yu N; Stolyarov GP; Bondarenko MP; Tovetyko OI; Fatakhova TI; Pogosyan NP
Acta Virol; 1975 Nov; 19(6):499. PubMed ID: 55066
[No Abstract] [Full Text] [Related]
29. Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state.
Feinman SV; Berris B; Cooter N; Sinclair JC; Wrobel DM
Hepatogastroenterology; 1982 Apr; 29(2):58-61. PubMed ID: 7084885
[TBL] [Abstract][Full Text] [Related]
30. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis.
Colombo M; Cambieri R; Rumi MG; Ronchi G; Del Ninno E; De Franchis R
Gastroenterology; 1983 Aug; 85(2):235-9. PubMed ID: 6345255
[TBL] [Abstract][Full Text] [Related]
31. Assessment of splenic functions in patients with hepato-splenic schistosomiasis using non-invasive techniques.
Kamel R; Abbas MM; Metwally DM; Ezzat AG; El-Azzazi H; Saleh WA
J Egypt Soc Parasitol; 1999; 29(1):203-13. PubMed ID: 12561900
[TBL] [Abstract][Full Text] [Related]
32. [Atypical aspects of typhoid fever occurring in patients with hepatosplenic schistosomiasis. Study of 29 cases].
Ferreira JM; Bassoi ON; Shiroma M
Rev Inst Med Trop Sao Paulo; 1975; 17(6):368-79. PubMed ID: 1219978
[No Abstract] [Full Text] [Related]
33. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
[TBL] [Abstract][Full Text] [Related]
34. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes.
Tsega E; Nordenfelt E; Hansson BG; Mengesha B; Lindberg J
Ethiop Med J; 1992 Apr; 30(2 Suppl):1-33. PubMed ID: 1319901
[TBL] [Abstract][Full Text] [Related]
35. Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.
Sinkala E; Zyambo K; Besa E; Kaonga P; Nsokolo B; Kayamba V; Vinikoor M; Zulu R; Bwalya M; Foster GR; Kelly P
Am J Trop Med Hyg; 2018 Apr; 98(4):1152-1158. PubMed ID: 29436337
[TBL] [Abstract][Full Text] [Related]
36. [Asymptomatic carriers of hepatitis B associated antigen (HBsAg) in blood donors in Quebec].
Valet JP; Rousseau C; Ackermann HW
Union Med Can; 1977 Jul; 106(7):966-9. PubMed ID: 898408
[No Abstract] [Full Text] [Related]
37. Hepatitis C virus infection in Schistosomiasis mansoni in Brazil.
Pereira LM; Melo MC; Saleh MG; Massarolo P; Koskinas J; Domingues AL; Spinelli V; Mies S; Williams R; McFarlane IG
J Med Virol; 1995 Apr; 45(4):423-8. PubMed ID: 7545213
[TBL] [Abstract][Full Text] [Related]
38. [Active chronic hepatitis and decompensated schistosomiasis].
Andrade ZA; Sadigursky M; Gomes LS
AMB Rev Assoc Med Bras; 1978 Nov; 24(11):366-8. PubMed ID: 85318
[No Abstract] [Full Text] [Related]
39. Hepatitis B surface antigen in serum, ascitic fluid and saliva in advanced hepatosplenic schistosomiasis.
Farrag SA; Makarem SS; Montaser MF; el-Okbi LM; Khalil I
J Egypt Soc Parasitol; 1988 Jun; 18(1):247-52. PubMed ID: 3373053
[No Abstract] [Full Text] [Related]
40. Enhanced neutrophil apoptosis in neutropenic patients with hepatosplenic schistosomiasis: evidence of serum Fas ligand.
Aref S; El Refaei MF; Sakrana M; El-Nemre H
Hematology; 2004 Feb; 9(1):71-8. PubMed ID: 14965872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
